Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Assets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInterest Coverage RatioInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on SalesTimes Interest Earned

MDxHealth (MDXH) Equity Average (2021 - 2024)

MDxHealth has reported Equity Average over the past 4 years, most recently at $11.0 million for Q4 2024.

  • For Q4 2024, Equity Average rose 33.44% year-over-year to $11.0 million; the TTM value through Dec 2024 reached $11.0 million, up 33.44%, while the annual FY2025 figure was $1.4 million, 87.54% down from the prior year.
  • Equity Average was $11.0 million for Q4 2024 at MDxHealth, up from $8.3 million in the prior quarter.
  • Across five years, Equity Average topped out at $28.1 million in Q4 2022 and bottomed at $8.3 million in Q4 2023.
  • The 4-year median for Equity Average is $18.7 million (2021), against an average of $18.4 million.
  • Year-over-year, Equity Average plummeted 70.61% in 2023 and then skyrocketed 33.44% in 2024.
  • Over 4 years, Equity Average stood at $26.4 million in 2021, then rose by 6.57% to $28.1 million in 2022, then tumbled by 70.61% to $8.3 million in 2023, then skyrocketed by 33.44% to $11.0 million in 2024.
  • The last three reported values for Equity Average were $11.0 million (Q4 2024), $8.3 million (Q4 2023), and $28.1 million (Q4 2022) per Business Quant data.